Hubbry Logo
Internal bleedingInternal bleedingMain
Open search
Internal bleeding
Community hub
Internal bleeding
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Internal bleeding
Internal bleeding
Internal bleeding
View on Wikipedia
from Wikipedia
Internal bleeding
Other namesInternal hemorrhage
Internal bleeding in the brain
SpecialtyVascular surgery, hematology, emergency medicine
ComplicationsHemorrhagic shock, exsanguination

Internal bleeding (also called internal haemorrhage) is a loss of blood from a blood vessel that collects inside the body, and is not usually visible from the outside.[1] It can be a serious medical emergency but the extent of severity depends on bleeding rate and location of the bleeding (e.g. head, torso, extremities). Severe internal bleeding into the chest, abdomen, pelvis, or thighs can cause hemorrhagic shock or death if proper medical treatment is not received quickly.[2] Internal bleeding is a medical emergency and should be treated immediately by medical professionals.[2]

Signs and symptoms

[edit]

Signs and symptoms of internal bleeding may vary based on location, presence of injury or trauma, and severity of bleeding. Common symptoms of blood loss may include:

  • Lightheadedness
  • Fatigue
  • Urinating less than usual
  • Confusion
  • Fast heart rate
  • Pale and/or cold skin
  • Thirst
  • Generalized weakness

Visible signs of internal bleeding include:

  • Blood in the urine
  • Dark black stools
  • Bright red stools
  • Bloody noses
  • Bruising
  • Throwing up blood

Of note, it is possible to have internal bleeding without any of the above symptoms, and pain may or may not be present.[3]

A patient may lose more than 30% of their blood volume before there are changes in their vital signs or level of consciousness.[4] This is called hemorrhagic or hypovolemic shock, which is a type of shock that occurs when there is not enough blood to reach organs in the body.[5]

Causes

[edit]

Internal bleeding can be caused by a broad number of things and can be broken up into three large categories:

  • Trauma, or direct injury to blood vessels within the body cavity
  • Genetic and acquired conditions, along with various medications, that result in an increased bleeding risk
  • Other

Traumatic

[edit]

The most common cause of death in trauma is bleeding.[6] Death from trauma accounts for 1.5 million of the 1.9 million deaths per year due to bleeding.[4]

There are two types of trauma: penetrating trauma and blunt trauma.[2]

Non-traumatic

[edit]

A number of pathological conditions and diseases can lead to internal bleeding. These include:

Other

[edit]
This stomach with Linitis plastica (Brinton's disease) can cause internal bleeding

Internal bleeding could be a result of complications following surgery or other medical procedures. Some medications may also increase a person's risk for bleeding, such as anticoagulant drugs or antiplatelet drugs in the treatment of coronary artery disease.[10]

Diagnosis

[edit]

Vital signs

[edit]

Blood loss can be estimated based on heart rate, blood pressure, respiratory rate, and mental status.[11] Blood is circulated throughout the body and all major organ systems through a closed loop system. When there is damage to the blood vessel or the blood is thinner than the physiologic consistency, blood can exit the vessel which disrupts this close-looped system. The autonomic nervous system (ANS) responds in two large ways as an attempt to compensate for the opening in the system. These two actions are easily monitored by checking the heart rate and blood pressure. Blood pressure will initially decrease due to the loss of blood. This is where the ANS comes in and attempts to compensate by contracting the muscles that surround these vessels. As a result, a person who is bleeding internally may initially have a normal blood pressure. When the blood pressure falls below the normal range, this is called hypotension. The heart will start to pump faster causing the heart rate to increase, as an attempt to get blood delivered to vital organ systems faster. When the heart beats faster than the healthy and normal range, this is called tachycardia. If the bleeding is not controlled or stopped, a patient will experience tachycardia and hypotension, which altogether is a state of shock, called hemorrhagic shock.

Advanced trauma life support (ATLS) by the American College of Surgeons separates hemorrhagic shock into four categories.[12][4][13]

Classification of Hemorrhagic Shock[12][4][13]
Estimated blood loss Heart rate (per minute) Blood pressure Pulse pressure (mmHg) Respiratory rate (per minute) Other
Class I hemorrhage < 15% Normal or minimally elevated Normal Normal Normal
  • Slightly anxious
Class II hemorrhage 15 - 30% 100 - 120 Normal or minimally decreased systolic blood pressure Narrowed 20 - 30
Class III hemorrhage 30 - 40% 120 - 140 Systolic blood pressure < 90 mmHg or change in blood pressure > 20-30% from presentation Narrowed 30 - 40
  • Altered mental status (anxious, confused)
  • Decreased urine output
Class IV hemorrhage > 40% > 140 Systolic blood pressure < 90 mmHg Narrowed (< 25 mmHg) >35
  • Significantly altered mental status (confused, lethargic)
  • Cool, clammy skin with delayed capillary refill
  • Significantly decreased or absent urine output

Assessing circulation occurs after assessing the patient's airway and breathing (ABC (medicine)).[5] If internal bleeding is suspected, a patient's circulatory system is assessed through palpation of pulses and doppler ultrasonography.[2]

Physical examination

[edit]

It is important to examine the person for visible signs that may suggest the presence of internal bleeding and/or the source of the bleed.[2] Some of these signs may include:

Imaging

[edit]

If internal bleeding is suspected a FAST exam may be performed to look for bleeding in the abdomen.[2][12]

If the patient has stable vital signs, they may undergo diagnostic imaging such as a CT scan.[4] If the patient has unstable vital signs, they may not undergo diagnostic imaging and instead may receive immediate medical or surgical treatment.[4]

Treatment

[edit]

Management of internal bleeding depends on the cause and severity of the bleed. Internal bleeding is a medical emergency and should be treated immediately by medical professionals.[2]

Fluid replacement

[edit]

If a patient has low blood pressure (hypotension), intravenous fluids can be used until they can receive a blood transfusion. In order to replace blood loss quickly and with large amounts of IV fluids or blood, patients may need a central venous catheter.[12] Patients with severe bleeding need to receive large quantities of replacement blood via a blood transfusion. As soon as the clinician recognizes that the patient may have a severe, continuing hemorrhage requiring more than 4 units in 1 hour or 10 units in 6 hours, they should initiate a massive transfusion protocol.[12] The massive transfusion protocol replaces red blood cells, plasma, and platelets in varying ratios based on the cause of the bleeding (traumatic vs. non-traumatic).[4]

Stopping the bleeding

[edit]

It is crucial to stop the internal bleeding immediately (achieve hemostasis) after identifying its cause.[4] The longer it takes to achieve hemostasis in people with traumatic causes (e.g. pelvic fracture) and non-traumatic causes (e.g. gastrointestinal bleeding, ruptured abdominal aortic aneurysm), the higher the death rate is.[4]

Unlike with external bleeding, most internal bleeding cannot be controlled by applying pressure to the site of injury.[12] Internal bleeding in the thorax and abdominal cavity (including both the intraperitoneal and retroperitoneal space) cannot be controlled with direct pressure (compression). A patient with acute internal bleeding in the thorax after trauma should be diagnosed, resuscitated, and stabilized in the Emergency Department in less than 10 minutes before undergoing surgery to reduce the risk of death from internal bleeding.[4] A patient with acute internal bleeding in the abdomen or pelvis after trauma may require use of a REBOA device to slow the bleeding.[4] The REBOA has also been used for non-traumatic causes of internal bleeding, including bleeding during childbirth and gastrointestinal bleeding.[4]

Internal bleeding from a bone fracture in the arms or legs may be partially controlled with direct pressure using a tourniquet.[12] After tourniquet placement, the patient may need immediate surgery to find the bleeding blood vessel.[4]

Internal bleeding where the torso meets the extremities ("junctional sites" such as the axilla or groin) cannot be controlled with a tourniquet; however there is an FDA approved device known as an Abdominal Aortic and Junctional Tourniquet (AAJT) designed for proximal aortic control, although very few studies examining its use have been published.[14][15][16][17][18][19] For bleeding at junctional sites, a dressing with a blood clotting agent (hemostatic dressing) should be applied.[4]

A campaign is to improve the care of the bleeding known as Stop The Bleed campaign is also taking place.[20]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Internal bleeding

View on Grokipedia
from Grokipedia
Internal bleeding, also known as internal hemorrhage, is the loss of from damaged blood vessels that accumulates within the body's tissues, organs, or cavities, rather than exiting through the skin or natural orifices. Unlike external bleeding, it often lacks visible signs and can range from mild, self-resolving episodes to severe, life-threatening events that lead to , organ damage, or death if untreated. The primary causes of internal bleeding include traumatic injuries, such as blunt force from car accidents or falls that tear blood vessels, and penetrating wounds like stabbings or gunshots that puncture them. Non-traumatic causes encompass medical conditions like gastrointestinal ulcers, ruptured aneurysms, ectopic pregnancies, or bleeding disorders such as hemophilia, as well as complications from , medications, or infections like viral hemorrhagic fevers. Bleeding can occur in various sites, including the , chest, , joints, or , with the severity often classified by the percentage of lost: Class I (up to 15%) may show minimal symptoms, while Class IV (over 40%) involves profound and is frequently fatal without intervention. Symptoms of internal bleeding vary by location and extent but commonly include abdominal or , , , rapid heartbeat, low , and ; more severe indicators involve , fainting, cool clammy , or visible bruising (ecchymosis). In cases like intracranial bleeding, symptoms may manifest as severe , seizures, or altered , while gastrointestinal involvement can present as dark stools, vomiting blood, or . Diagnosis typically requires urgent medical evaluation, including , vital sign monitoring, laboratory tests for blood counts and clotting factors, and imaging such as , CT scans, or to locate and assess the bleed. Treatment depends on the cause, location, and severity, with mild cases sometimes resolving with rest and monitoring, but severe internal bleeding demands immediate hospitalization. Interventions may include intravenous fluids or blood transfusions to stabilize , medications like to promote clotting, and surgical procedures such as for abdominal bleeds or to seal vessels. Prevention strategies focus on reducing risk factors, such as managing to avoid aneurysms, avoiding trauma through safety measures, and carefully monitoring use in at-risk patients. Globally, uncontrolled hemorrhages from trauma and other causes contribute significantly to mortality, particularly in younger populations, underscoring the need for rapid recognition and response.

Overview

Definition

Internal bleeding, also known as internal hemorrhage, refers to the loss of from damaged vessels that accumulates within the body's tissues, organs, or cavities, remaining invisible from the exterior. This condition arises when escapes the circulatory system and pools internally, distinguishing it from external hemorrhage where bleeding is apparent on the skin's surface. Unlike visible wounds, internal bleeding can proceed undetected, progressively reducing and potentially resulting in . Common anatomical sites for internal bleeding include closed body cavities such as the peritoneal cavity (abdomen), pleural cavity (chest), and pericardial cavity (around the heart), as well as potential spaces like the retroperitoneal area behind the abdominal lining. It may also occur within the gastrointestinal tract, cranial spaces, spinal canal, or surrounding major bones and organs. These locations allow blood to collect without immediate external signs, complicating early recognition. Internal bleeding is broadly classified by severity into mild, moderate, and severe categories, often aligned with the extent of blood loss: mild involving up to 15% of total with minimal or no symptoms, moderate at 15-30% leading to noticeable effects like , and severe exceeding 30% which can cause profound instability. It is further categorized as acute, characterized by sudden and rapid blood loss, or chronic, involving slower accumulation over time. Severe cases may culminate in hemorrhagic shock if untreated.

Epidemiology

Internal bleeding represents a significant burden, with traumatic hemorrhage accounting for an estimated 1.5 million deaths worldwide each year. This figure constitutes a substantial portion of the approximately 4.4 million annual global deaths from injuries, where hemorrhage contributes to 30-40% of trauma-related fatalities. Regional variations are pronounced, with low- and middle-income countries bearing over 90% of the injury-related burden due to limited access to emergency care, while high-income regions report lower but still notable rates, such as over 60,000 traumatic hemorrhage deaths annually in the United States. Non-traumatic internal bleeding, such as , also contributes substantially to global mortality, with an estimated 3.3 million deaths in 2021. Demographic patterns reveal a higher incidence among males, with a male-to-female ratio of approximately 2:1, particularly in traumatic cases where males comprise about 80% of patients. Age distributions show peaks in the 15-44 year range for trauma-related internal bleeding, driven by accidents and , while non-traumatic forms, such as those from vascular rupture or gastrointestinal sources, predominate in the elderly population over 65 years. Urban-rural disparities exist, with urban areas experiencing higher rates of traumatic incidents due to traffic and , contrasted by rural challenges from delayed medical access. Trends indicate a rising global incidence, influenced by aging populations that increase non-traumatic cases and the expanding use of anticoagulants, which elevate bleeding risks in older adults. Data from 2016 to 2020 show increases in iatrogenic bleeding, with oral anticoagulant-related emergency visits rising from 230,000 in 2016 to over 300,000 in 2020 as of that period, partly linked to procedural complications amid heightened healthcare demands.

Causes

Traumatic causes

Traumatic causes of internal bleeding arise from external forces that disrupt blood vessels or organs, leading to hemorrhage within body cavities or tissues. These injuries are primarily classified into blunt and penetrating trauma, each involving distinct mechanisms of vessel and organ damage. Blunt trauma results from non-penetrating impacts that cause compression, shearing, or tearing forces, while penetrating trauma involves objects that breach the skin and underlying structures. Blunt trauma commonly occurs in motor vehicle accidents, falls, and assaults, where rapid deceleration or crushing forces lead to internal injuries. For instance, high-speed collisions can cause splenic or liver lacerations due to the organs' vulnerability to shearing against fixed structures like the spine. Deceleration injuries, such as those from sudden stops in vehicles, may also produce aortic tears at points of mobility, like the , resulting in massive retroperitoneal or mediastinal bleeding. These mechanisms involve pathophysiological vessel disruption through tensile forces, as detailed in the mechanisms of hemorrhage section. Penetrating trauma, often from gunshot or stab wounds to the , directly perforates vascular structures or organs, leading to rapid . Gunshot wounds create high-velocity tissue disruption and cavitation, frequently injuring major vessels like the or mesenteric arteries, while stab wounds cause linear lacerations that may sever smaller branches or solid organs such as the liver. In the , these injuries commonly result in mesenteric vessel tears, compromising blood supply to the intestines and causing . Thoracic penetration can produce through intercostal vessel or lung laceration, exacerbated by associated rib fractures that puncture pleural spaces. Traumatic internal bleeding accounts for a significant proportion of emergency cases, representing the leading cause of hemorrhage in trauma patients, with sources including abdominal (about 44%), thoracic (20%), and pelvic sites. In conflict zones, such as war-affected regions, the incidence is notably higher, with abdominal trauma comprising 18-25% of injuries compared to lower rates in civilian settings.

Non-traumatic causes

Non-traumatic causes of internal bleeding arise from underlying medical conditions that compromise vascular integrity or hemostatic mechanisms without external injury. These etiologies often involve chronic diseases affecting the , vascular structures, blood clotting processes, or malignancies, leading to spontaneous hemorrhage that can be life-threatening if undetected. Common presentations include gastrointestinal hemorrhage, , or organ-specific bleeds, with diagnosis relying on clinical suspicion and imaging or . Additionally, gynecological conditions, such as ruptured , can cause severe intraperitoneal bleeding. Infectious diseases, including viral hemorrhagic fevers (e.g., , dengue), can result in internal bleeding through and . Gastrointestinal sources are among the most frequent non-traumatic causes, particularly , which erode the mucosal lining of the or , resulting in that manifests as or . Approximately one-quarter of stem from , often exacerbated by factors like infection or chronic NSAID use, though the bleeding itself is endogenous. Esophageal or , typically secondary to from liver , can rupture and cause massive , with variceal hemorrhage accounting for up to 10-20% of such cases in affected populations. In the lower gastrointestinal tract, leads to bleeding in about 3-15% of patients with colonic diverticula, where fragile vasa recta vessels at the diverticular neck rupture, often presenting as painless and contributing to nearly 200,000 annual hospital admissions in the United States. Vascular disorders represent another critical category, where structural weaknesses in major arteries predispose to dissection or rupture. involves a tear in the intima of the , allowing blood to enter the media and create a false lumen, which can extend and lead to hemorrhage into the , pleura, or retroperitoneum, occurring spontaneously in conditions like or connective tissue disorders. Ruptured abdominal aortic aneurysms, prevalent in elderly individuals with , cause rapid retroperitoneal or intraperitoneal ; these aneurysms affect about 1-2% of people over 65, with rupture mortality exceeding 80% due to if untreated. Hematological coagulopathies disrupt normal clotting, promoting spontaneous internal bleeding in joints, muscles, or viscera. Hemophilia A and B, inherited deficiencies of or IX respectively, result in hemarthrosis and intramuscular hematomas as hallmark spontaneous bleeds, affecting approximately 1 in 5,000 males and leading to recurrent internal hemorrhages without trauma. (DIC), an acquired syndrome often triggered by , , or obstetric complications, consumes clotting factors and platelets, causing widespread microvascular followed by bleeding into organs or the . Oncologic conditions contribute through direct tumor invasion or erosion into vascular structures, precipitating hemorrhage. In pancreatic cancer, tumor growth can invade the gastroduodenal artery or erode into the , causing severe in up to 10-20% of advanced cases, often as a presenting feature. Hepatic cancers, such as , may rupture spontaneously due to rapid tumor expansion and , leading to ; this occurs in 3-15% of patients with large tumors and carries a high from acute blood loss.

Iatrogenic causes

Iatrogenic causes of internal arise from medical interventions, including surgical procedures, pharmacological therapies, and diagnostic or therapeutic interventions, which can disrupt vascular integrity or impair hemostatic mechanisms. These complications, though relatively uncommon, contribute significantly to morbidity in hospitalized patients, often requiring urgent reintervention. Unlike spontaneous or traumatic hemorrhages, iatrogenic is directly linked to healthcare delivery, with risks amplified by patient factors such as underlying conditions or procedural complexity. Surgical complications represent a primary iatrogenic source, particularly postoperative hemorrhage due to inadequate during vessel ligation or tissue manipulation. For instance, after splenectomy, bleeding may occur from the splenic hilum or accessory vessels, with reported incidences ranging from 1.6% to 3% in large series, often necessitating return to the operating room within the first 24 hours. Injuries to abdominal or pelvic veins during oncologic resections or procedures involving difficult anatomic exposure, such as prior surgeries or radiation-altered tissues, further elevate risks, occurring in up to 65% of venous cases attributed to these factors. These events can lead to intraperitoneal or retroperitoneal accumulation, exacerbating hemodynamic instability. Pharmacological agents, notably anticoagulants and antiplatelet drugs, substantially increase the propensity for internal by inhibiting pathways. Warfarin, a , is associated with major bleeding events in approximately 2-3% of users annually, while direct oral anticoagulants (DOACs) like or show comparable or slightly lower rates but still elevate risks when combined with antiplatelets. Antiplatelet therapy with aspirin alone heightens gastrointestinal or intracranial bleed likelihood by 50-100% in susceptible populations, and dual or triple regimens (e.g., aspirin plus clopidogrel and a DOAC) can amplify major bleeding incidence to 10% or more in the first year post-initiation, particularly in patients with or recent stents. These risks are dose-dependent and often manifest as retroperitoneal or intra-abdominal hemorrhages. Interventional procedures, such as and , carry risks of vascular or puncture-site hemorrhage. access during coronary can result in retroperitoneal in 0.2-0.6% of cases, a potentially life-threatening accumulation that may exceed 1 liter and cause if undetected. Endoscopic interventions like or (ERCP) similarly predispose to , with incidences of 1-2% for post-ERCP hemorrhage, often from sphincterotomy sites or inadvertent duodenal . These complications are more frequent in anticoagulated patients or those with procedural technical challenges. Post-2020, iatrogenic bleeding incidents have risen in certain cohorts due to heightened use of invasive procedures amid the , including support and vascular access for therapeutics. In critically ill patients, iatrogenic arterial bleeding occurred in about 30% of cases, frequently following insertions or central line placements, correlating with overall procedural volume surges. This trend underscores the interplay with pandemic-related coagulopathies, amplifying intervention-associated risks.

Pathophysiology

Mechanisms of hemorrhage

Internal bleeding begins with the failure of vessel integrity, where vessels rupture, erode, or become fragile, allowing to extravasate into surrounding tissues or body cavities. This process can occur due to mechanical disruption, such as tears in vessel walls, or degenerative changes like weakening of arterial walls in aneurysms. For instance, in hypertensive conditions, elevated intravascular pressure can exceed the tensile strength of the vessel wall, leading to rupture and subsequent hemorrhage. Disruption of the cascade further exacerbates hemorrhage by impairing the body's response. Hemostasis normally involves platelet adhesion and aggregation to form a primary plug, followed by activation of the coagulation factors—such as fibrinogen converting to —to stabilize the clot. Failures in this cascade, including deficiencies in clotting factors (e.g., factors VIII or IX) or impaired platelet function, prevent effective clot formation, allowing to continue unchecked. Conditions like trauma-induced , characterized by dilution of coagulation factors, , and , compound this disruption, leading to widespread hemostasis failure. Pressure dynamics play a critical role in initiating and propagating hemorrhage, as the force exerted by blood against vessel walls determines whether a weakened site will breach. In scenarios like aneurysmal rupture, chronic hypertension increases wall stress, often following Laplace's law where tension is proportional to pressure and radius, predisposing to failure. Once initiated, the pressure gradient between the vascular lumen and surrounding tissues drives continued extravasation. The physics of volume loss governs the initial rate of bleeding, influenced by the size of the vessel defect and the across it. According to Poiseuille's law, blood flow through the breach is proportional to the of the and the pressure difference, divided by the length of the vessel segment, meaning even small increases in opening size dramatically accelerate hemorrhage. For example, arterial bleeds from larger vessels, such as the , can result in rapid due to high flow rates under systemic pressure. Traumatic vessel tears, as one trigger, can initiate this process by creating such defects.

Hemodynamic consequences

Internal bleeding leads to , a reduction in intravascular volume that impairs and tissue , progressing through four classes of hemorrhagic shock as classified by the (ATLS) guidelines. Class I involves up to 15% blood volume loss (approximately 750 mL in adults), with minimal hemodynamic changes and no significant clinical effects. Class II entails 15-30% loss (750-1500 mL), marked by early compensatory and anxiety but maintained . In Class III, 30-40% volume loss (1500-2000 mL) results in exceeding 120 beats per minute, , and decreased urine output, indicating substantial circulatory compromise. Class IV, exceeding 40% loss (>2000 mL), features profound , rapid thready pulse, and obtundation, often leading to imminent cardiovascular collapse. The body initially responds to through activation, triggering to redistribute blood to vital organs and to sustain . This is augmented by neuroendocrine mechanisms, including increased antidiuretic hormone release to promote fluid retention and renin-angiotensin-aldosterone system activation to enhance and sodium conservation. These compensatory responses maintain during early stages but eventually fail as blood loss exceeds 30-40%, leading to with widespread organ hypoperfusion. Prolonged hypoperfusion causes organ-specific dysfunction; renal flow decreases, precipitating through ischemia and tubular necrosis. Cerebral hypoperfusion manifests as altered mental status, such as confusion, due to inadequate oxygen delivery to the . In cases of pericardial hemorrhage, accumulation compresses the heart, causing with impaired diastolic filling and reduced . Hemorrhagic shock progresses from compensated (Classes I-II) to progressive decompensated (Class III) and irreversible stages (Class IV), where cellular damage and become self-perpetuating, leading to multi-organ failure. Mortality escalates sharply beyond 40% volume loss, with survival rates dropping exponentially as irreversible hypoperfusion sets in, often resulting in death within hours if untreated.

Signs and symptoms

Early manifestations

Early manifestations of internal bleeding often arise from mild , typically involving less than 20% of total loss, where the body activates compensatory mechanisms to maintain to vital organs. Common general symptoms during this phase include , , and anxiety, which reflect the initial physiological response to reduced circulating volume without progression to overt shock. These symptoms stem from activation, which prioritizes blood flow to the and heart while causing subtle systemic effects. Localized clues provide site-specific indicators that may appear early, depending on the bleeding's location. For example, can cause due to blood accumulation in the , presenting as a sensation of fullness or mild swelling. Similarly, may manifest as from blood irritating the pleural space and compressing the , occurring without immediate hemodynamic instability. In cases of thoracic trauma, such as from a severe fall, early signs may include coughing up bright red frothy blood (hemoptysis), chest pain, difficulty breathing with gurgling or whistling sounds, and shallow erratic breaths. These signs highlight the importance of considering the injury site in early recognition. Behavioral changes, such as restlessness and , frequently accompany early internal bleeding as a result of catecholamine release, which induces peripheral and heightened . arises from reduced skin blood flow, while restlessness signals the body's stress response to . These manifestations typically emerge within minutes to hours following the onset of , often before significant vital sign changes like pronounced or develop. This early window allows for potential intervention prior to advancement in hypovolemic progression.

Location-specific symptoms

Symptoms of internal bleeding vary depending on the site of the hemorrhage and can provide important clues to the location of bleeding. Common location-specific manifestations include:
  • Lungs: Coughing up blood (hemoptysis), shortness of breath, chest pain.
  • Esophagus and stomach: Vomiting blood (bright red or coffee-ground appearance), black tarry stools (melena), abdominal pain.
  • Liver and spleen: Abdominal pain, swelling or distension, bruising, signs of shock (dizziness, rapid pulse, weakness).
  • Kidneys and bladder: Blood in urine (hematuria), flank or lower abdominal pain.
  • Pelvic cavity: Pelvic or lower abdominal pain, possible blood in urine or stool, swelling.
General signs across locations include lightheadedness, fatigue, pale skin, rapid heart rate, low blood pressure, and confusion. If internal bleeding is suspected, seek emergency medical care immediately, as it can rapidly become life-threatening.

Advanced signs

Advanced signs of internal bleeding indicate substantial blood volume loss, typically exceeding 30% of total circulating volume, leading to decompensated and systemic hypoperfusion. Profound , defined as systolic below 90 mmHg, emerges in class IV hemorrhage (>40% loss), reflecting inadequate and compensatory failure. , or reduced urine output to less than 0.5 mL/kg/hour, signals renal hypoperfusion and impending in this stage. Cold, clammy skin results from intense peripheral and diaphoresis as the body prioritizes vital organ . Visible manifestations often become evident with ongoing hemorrhage, providing direct clues to the bleeding site. , the vomiting of bright red or coffee-ground blood, suggests upper gastrointestinal involvement such as from peptic ulcers or . , characterized by black, tarry stools, arises from digested blood in the upper GI tract, while —visible blood in urine—points to urinary tract or renal sources. Ecchymosis may appear as (periumbilical bruising) or (flank discoloration), both indicative of retroperitoneal or intra-abdominal hemorrhage, such as in or ruptured . Neurological symptoms arise from cerebral hypoperfusion due to sustained . Altered mental status, ranging from to or , reflects inadequate oxygen delivery to the in class III and IV shock. Syncope, or transient loss of , occurs as a direct consequence of global cerebral hypoperfusion, often preceding more profound obtundation. Multi-organ dysfunction heralds a critical phase, with hypoperfusion causing sequential organ failure. may develop from hepatic ischemia, impairing metabolism and leading to elevated serum levels. Dyspnea and signal pulmonary involvement, such as from secondary to shock-induced inflammation and hypoxia. These signs, progressing from subtler early manifestations like , demand immediate intervention to avert irreversible .

Diagnosis

Clinical assessment

The clinical assessment of suspected internal bleeding relies on a structured history-taking and to identify clues of hemorrhage, guiding further diagnostic and therapeutic decisions. History-taking begins with elucidating the mechanism of , such as blunt from accidents or falls, which can cause solid organ lacerations leading to concealed loss. Medication history is essential, particularly inquiring about anticoagulants (e.g., ) or antiplatelet agents (e.g., aspirin), as these increase bleeding risk and severity in both traumatic and non-traumatic scenarios. The timing of symptom onset—acute versus insidious—helps differentiate life-threatening hypovolemic states from slower bleeds, such as those from gastrointestinal sources. Physical examination follows a systematic approach, starting with inspection for external signs of internal pathology, including abdominal distension suggestive of hemoperitoneum or ecchymosis like the seat-belt sign across the abdomen, which correlates with intra-abdominal injury. Palpation evaluates for tenderness, rebound, or guarding—voluntary muscle tensing that diminishes with distraction or involuntary rigidity indicating peritoneal irritation from blood accumulation. Auscultation assesses bowel sounds, where hypoactive or absent tones signal paralytic ileus often associated with internal abdominal hemorrhage or peritonitis. Vital signs are integrated throughout the assessment to detect hemodynamic instability. Trends include (heart rate >100 bpm) and (respiratory rate >20 breaths/min) as early compensatory responses, progressing to (systolic blood pressure <90 mmHg) in advanced cases. Narrowing pulse pressure—due to disproportionate drops in systolic versus diastolic blood pressure—signals Class III (30-40% blood volume loss) or Class IV (>40% loss) hemorrhagic shock, prompting urgent intervention. Bedside tools enhance suspicion of internal bleeding without delaying care; the Focused Assessment with Sonography for Trauma (FAST) provides a rapid, non-invasive screen for free intraperitoneal or pericardial fluid in unstable trauma patients, with sensitivity for detecting >250 mL of blood.

Laboratory investigations

Laboratory investigations play a crucial role in confirming and quantifying internal bleeding by assessing blood loss, , and tissue hypoperfusion. A (CBC) is essential, with serial measurements of and to detect drops indicative of significant hemorrhage; for instance, a level below 10 g/dL often signals substantial blood loss requiring intervention. Platelet count from the CBC helps identify , which can exacerbate bleeding due to trauma-induced . Coagulation panels, including prothrombin time (PT), international normalized ratio (INR), and activated partial thromboplastin time (aPTT), are routinely performed to evaluate clotting function; prolonged values suggest , which affects up to 35% of trauma patients with major hemorrhage. Metabolic panels measure lactate levels, where elevations above 4 mmol/L indicate hypoperfusion and anaerobic , correlating with shock severity and poor outcomes. Base deficit, derived from arterial blood gas analysis, quantifies ; values greater than 2 mmol/L denote mild shock, while more than 6 mmol/L indicate moderate to severe cases, aiding in prognostic assessment. Type and crossmatch testing, involving ABO/Rh typing and compatibility assessment, is performed to prepare for blood transfusions in anticipation of ongoing or massive hemorrhage. Emerging point-of-care viscoelastic tests, such as (TEG) and rotational (ROTEM), provide rapid assessment of by evaluating clot formation dynamics; guidelines from 2015 onward recommend their use in trauma to guide targeted hemostatic therapy, predicting transfusion needs earlier than conventional tests. These findings complement the hemodynamic consequences of by providing objective data on the extent of blood loss and organ .

Imaging techniques

Ultrasound imaging, particularly the extended Focused Assessment with Sonography for Trauma (eFAST), serves as a rapid, bedside tool for detecting free intraperitoneal, pericardial, or pleural fluid—typically indicative of hemorrhage—in hemodynamically unstable trauma patients. The eFAST protocol involves scanning multiple views, including the right upper quadrant, left upper quadrant, pelvic region, pericardial sac, and pleural spaces, to identify hypoechoic fluid collections suggestive of ; it is highly sensitive for significant (>250-500 mL) but less so for retroperitoneal or solid organ injuries without free fluid. This modality is preferred in emergency settings due to its portability, lack of radiation, and ability to guide immediate interventions like operative exploration. Computed (CT) scanning represents the gold standard for evaluating internal bleeding in stable patients, providing detailed visualization of hemorrhage location, extent, and underlying vascular injury. Multidetector CT with intravenous contrast enables detection of active through "contrast blush," a focal area of high-attenuation contrast pooling that correlates with ongoing arterial bleeding and often necessitates angioembolization. In trauma contexts, non-contrast, arterial, and portal venous phases are typically acquired to differentiate from active bleed and assess organ parenchymal damage. Recent advancements include the integration of (AI) algorithms to assist in interpreting CT and images for faster detection of internal hemorrhage, particularly in trauma settings. As of 2025, AI models have shown improved accuracy in identifying abdominal injuries on CT scans and enhancing ultrasound-based detection of free fluid, aiding in rapid and reducing diagnostic errors. Other imaging modalities include (MRI) for characterizing chronic or subacute hemorrhages, where susceptibility-weighted sequences reveal blood degradation products across stages (e.g., deoxyhemoglobin in acute phase to in chronic), aiding in dating the bleed when CT is inconclusive. , often performed as , maps vascular anatomy prior to therapeutic in cases of suspected arterial hemorrhage, confirming and guiding selective placement. Imaging protocols vary by clinical suspicion and patient stability: in , a pan-CT (head-to-pelvis) is commonly employed to screen for multisystem hemorrhage, while targeted approaches—such as abdominal/pelvic CT for suspected gastrointestinal or retroperitoneal bleeds—minimize in non-trauma settings. These strategies prioritize rapid acquisition in unstable patients transitioning to eFAST or CT as needed.

Treatment

Initial resuscitation

Initial resuscitation in internal bleeding prioritizes stabilizing the patient's through an ABC (airway, , circulation) approach, with adaptations based on to minimize further hemorrhage while supporting vital organ . For traumatic causes, this involves rapid assessment and intervention guided by principles of damage control . In non-traumatic cases, such as gastrointestinal or aneurysmal bleeding, standard volume replacement is prioritized without permissive to avoid organ hypoperfusion. Airway patency must be ensured immediately, with supplemental oxygen administered via high-flow delivery if is present (SpO2 <94%) to optimize oxygen delivery despite reduced circulating volume. In cases of compromised airway protection, such as a Glasgow Coma Scale (GCS) score less than 8, endotracheal intubation is indicated to secure the airway and facilitate mechanical ventilation, though in hemorrhagic shock, this procedure should be performed judiciously to avoid exacerbating hypotension from positive pressure ventilation. Circulation is addressed through targeted fluid therapy, beginning with an initial bolus of 1-2 liters of crystalloid solution (e.g., normal saline or lactated Ringer's) to restore intravascular volume in hypotensive patients. However, excessive crystalloid use is limited to prevent dilutional coagulopathy, with early transition to blood products for ongoing resuscitation. In penetrating trauma or non-compressible hemorrhage without traumatic brain injury, permissive hypotension is employed, targeting a systolic blood pressure of 80-90 mmHg to avoid dislodging clots while maintaining coronary and cerebral perfusion. For non-traumatic bleeding, target normotension (systolic >90 mmHg) to ensure organ perfusion. For patients anticipated to require massive transfusion (defined as >10 units of in 24 hours), a massive transfusion protocol is activated, utilizing a 1:1:1 ratio of , , and platelets to approximate composition and mitigate . This balanced approach has been shown to reduce mortality compared to plasma-delayed strategies in severe trauma. Ongoing monitoring is essential to guide and prevent over-resuscitation, which can worsen bleeding through increased hydrostatic pressure. Invasive hemodynamic monitoring via central venous catheterization allows assessment of (CVP, target 8-12 mmHg for preload optimization) and central venous oxygen saturation (ScvO2, target >70% to evaluate tissue oxygenation). These parameters, combined with serial lactate levels and , help titrate fluids and transfusions while avoiding fluid overload.

Hemostasis strategies

Hemostasis strategies aim to directly interrupt or control the source of internal bleeding, prioritizing rapid intervention to prevent in hemodynamically unstable patients. These approaches are selected based on the bleeding site's location, injury severity, and patient stability, often integrated into a multidisciplinary protocol. For non-traumatic causes, site-specific interventions like for are prioritized. Surgical, endovascular, pharmacological, and non-operative methods each offer targeted control, with evidence supporting their use in specific contexts to minimize mortality from hemorrhage, which remains a leading cause of trauma-related death. For , a common non-traumatic cause, upper (within 24 hours) is the initial hemostatic approach for upper sources like ulcers or , using techniques such as clipping, thermal coagulation (e.g., bipolar electrocoagulation or heater probe), or injection therapy to achieve in lesions with high-risk (active , visible vessel). Success rates exceed 90% for non-variceal bleeds, with inhibitors administered post-procedure to prevent rebleeding. For lower , with similar interventions is preferred if stable; or is reserved for failures. Surgical interventions provide definitive hemostasis for major internal bleeding, particularly in the abdomen and thorax where direct access is feasible. Laparotomy serves as the cornerstone for abdominal bleeds, involving rapid exploration to identify and repair vascular or organ injuries, such as ligation of mesenteric vessels or splenectomy for splenic rupture. In cases of profound shock, coagulopathy, or hypothermia, damage control surgery employs abbreviated laparotomy with packing—placing laparotomy pads over bleeding sites to achieve temporary tamponade—followed by temporary abdominal closure and intensive care unit resuscitation before definitive repair in 24-72 hours. This staged approach reduces operative time and physiological insult, improving survival in severe trauma. For thoracic bleeding, damage control thoracotomy uses anterolateral incisions to access the pleural cavity, enabling packing of the mediastinum and pleura to control coagulopathic or low-pressure vessel hemorrhage, alongside techniques like tractotomy for pulmonary injuries or shunting for great vessel trauma. Temporary chest closure with vacuum-assisted dressings facilitates delayed reconstruction once physiology stabilizes. Endovascular techniques offer minimally invasive for accessible vascular sources, particularly in pelvic and splenic injuries. Angiographic involves catheter-directed delivery of embolic agents, such as coils or particles, to occlude bleeding arteries identified via contrast-enhanced imaging, providing rapid and effective control in pelvic trauma with arterial hemorrhage while avoiding open . This method achieves in up to 90% of cases, reducing transfusion requirements and morbidity in stable patients. Similarly, for splenic bleeds, selective targets pseudoaneurysms or active , enhancing non-operative success rates. Resuscitative endovascular balloon occlusion of the (REBOA) deploys an inflatable balloon in the to temporarily occlude distal flow, augmenting proximal perfusion and controlling intra-abdominal or pelvic hemorrhage as a bridge to definitive . Placed via femoral access in zones I (descending ) or III (distal ), REBOA rapidly stabilizes in refractory shock, though its use is limited by ischemia risks with prolonged occlusion beyond 30 minutes. Pharmacological agents complement mechanical hemostasis by addressing the that exacerbates internal bleeding. , an , inhibits plasminogen activation to stabilize clots and reduce in trauma-induced hyperfibrinolysis. The CRASH-2 trial demonstrated that early administration of 1 g intravenously within 3 hours of , followed by a 1 g over 8 hours, significantly lowers all-cause mortality (14.5% vs. 16.0%) and bleeding death (4.9% vs. 5.7%) in patients with significant hemorrhage, without increasing vascular occlusion events. This intervention is most effective when given promptly, ideally prehospital or upon arrival, and is now standard in trauma protocols for bleeding patients. Non-operative focuses on and supportive monitoring for select internal bleeds, avoiding in patients to preserve organ function. For low-grade blunt splenic injuries (AAST grades I-II), the Eastern Association for the Surgery of Trauma (EAST) guidelines recommend selective non-operative approaches in hemodynamically adults without , involving serial clinical assessments, monitoring, and , with success rates exceeding 90% in appropriate candidates. This strategy requires immediate access to or operating rooms for failure, defined by persistent or transfusion needs, and incorporates follow-up imaging only if clinical deterioration occurs. Such conservative care reduces rates and associated risks compared to routine operative intervention.

Supportive care

Supportive care in internal bleeding focuses on stabilizing the patient after initial to mitigate secondary and support recovery. This involves targeted interventions to address , maintain , provide nutrition, and vigilantly monitor for complications such as re-bleeding. management is a cornerstone of supportive care, particularly for patients on anticoagulants or with underlying bleeding diatheses. For individuals on experiencing , rapid reversal is achieved with intravenous to promote synthesis of clotting factors, combined with (PCC) to immediately replenish vitamin K-dependent factors II, VII, IX, and X. Four-factor PCC is preferred for its comprehensive factor replacement and faster action compared to , reducing the risk of ongoing hemorrhage. For direct oral anticoagulants (DOACs), specific reversal agents are used in life-threatening bleeds: (Praxbind) for (a ), administered as 5 g IV, and (Andexxa) for factor Xa inhibitors like or , given as a bolus followed by ; if unavailable, 4F-PCC (25-50 units/kg) is an alternative. In cases of uremic associated with renal failure, (DDAVP) is administered to enhance platelet function and reduce by promoting release from endothelial cells, typically at a dose of 0.3 μg/kg intravenously. This approach helps control mucosal and gastrointestinal bleeds without addressing the underlying directly. Organ support is essential to counteract the hypoperfusion and inflammatory sequelae of significant blood loss. In patients with refractory shock despite fluid , vasopressors such as norepinephrine are initiated to maintain above 65 mmHg, acting primarily as an alpha-1 to restore vascular tone in hemorrhagic shock. This is particularly critical in distributive components of shock following trauma or complicating bleeding. For those developing (ARDS) due to aspiration, transfusion-related , or systemic inflammation, with low tidal volumes (4-8 mL/kg predicted body weight) and is employed to improve oxygenation while minimizing ventilator-induced . Prone positioning may be added for severe cases to enhance ventilation-perfusion matching. Nutritional support begins once hemodynamic stability is achieved, typically within 24-48 hours post-stabilization, to preserve gut and immune function. Early enteral feeding via nasogastric or nasojejunal tubes is preferred over , as it reduces the incidence of infectious complications such as and bloodstream infections by maintaining mucosal barrier function and modulating the gut microbiome. In trauma patients with internal bleeding, this strategy has been associated with lower rates of wound infections and shorter stays compared to delayed feeding. Caloric goals are advanced gradually to avoid , starting at 20-25 kcal/kg/day. Ongoing monitoring protocols are vital to detect re-bleeding or deterioration early. Daily laboratory assessments, including , profile (PT/INR, aPTT, fibrinogen), and renal/hepatic function tests, guide adjustments in transfusions and supportive therapies. Serial imaging, such as computed tomography or , is performed based on clinical suspicion or protocol (e.g., every 24-48 hours in high-risk cases) to identify expanding hematomas or new bleeds, particularly in abdominal or retroperitoneal hemorrhage. Hemodynamic monitoring via arterial lines or ensures timely intervention for recurrent instability. These measures, integrated into multidisciplinary care, improve outcomes by facilitating proactive .

Complications and prognosis

Immediate complications

Internal bleeding can rapidly lead to due to significant loss, resulting in inadequate tissue perfusion and cellular hypoxia that progresses to multi-organ dysfunction if untreated. In severe cases, such as traumatic hemorrhagic shock, this often manifests as (AKI), with an incidence of approximately 29% among affected patients. AKI in this context arises from reduced renal flow and ischemic damage, contributing to higher morbidity and mortality rates in up to 28% of trauma intensive care unit admissions. Acute traumatic (ATC), a hemostatic derangement triggered by severe and hypoperfusion, exacerbates internal bleeding by impairing clot formation and promoting . ATC occurs in about 25% of patients upon hospital admission and is associated with increased transfusion requirements and mortality. This involves endothelial damage and activation of pathways, creating a vicious cycle that worsens hemorrhage volume and hemodynamic instability. Infections represent another immediate threat, particularly arising from during abdominal internal bleeding, where leakage of intestinal contents into the triggers and systemic inflammatory response. This can rapidly evolve into , characterized by and organ hypoperfusion, with high lethality if not surgically intervened. Additionally, transfusion-related acute (TRALI), a non-cardiogenic from donor antibodies in transfused blood products, can affect 13-20% of severely injured trauma patients receiving transfusions in some cohorts. Iatrogenic complications, such as , may develop from hematoma expansion within confined fascial spaces, compressing neurovascular structures and leading to ischemia. This is particularly noted in retroperitoneal or extremity from internal bleeding, especially under anticoagulation, where unchecked expansion elevates intracompartmental pressure beyond capillary thresholds. Prompt is essential to prevent irreversible muscle and damage in these cases.

Long-term outcomes

The long-term mortality associated with internal bleeding, particularly in traumatic cases, ranges from 10% to 20% overall, though it can reach up to 50% in elderly patients with comorbidities such as or . Recent meta-analyses indicate that administration of (TXA) can reduce mortality by approximately 17% in patients with significant bleeding, including gastrointestinal and traumatic sources, when given early. Survival trajectories improve with prompt intervention, but late deaths often stem from multi-organ failure or secondary infections persisting months post-event. Survivors frequently face chronic morbidity, including persistent that requires ongoing iron supplementation or therapy to address impaired following acute blood loss. Organ impairment is common, with up to 10% of cases involving permanent renal damage due to ischemic injury from hemorrhagic shock, leading to that necessitates long-term dialysis in severe instances. These effects can endure for years, contributing to reduced functional capacity and the need for multidisciplinary rehabilitation. Quality of life is often compromised by post-trauma disabilities, such as mobility limitations or from associated injuries, with —a common intervention for splenic rupture—elevating the risk of (OPSI) by 10- to 50-fold compared to the general population. Vaccinations and prophylactic antibiotics are recommended lifelong to mitigate this risk. Key prognostic factors include patient age (worse outcomes beyond 65 years), estimated bleed volume (greater than 40% blood loss correlating with higher fatality), and response time (delays over 60 minutes increasing mortality odds). The (RTS) provides a validated tool for , integrating physiological parameters like , systolic , and to estimate survival probability on a 0-12 scale.

Prevention

Trauma prevention

Preventing internal bleeding caused by trauma requires targeted strategies to mitigate high-risk activities and behaviors that lead to blunt or penetrating injuries. In road safety, the use of seat belts is one of the most effective measures, reducing the risk of serious crash-related injuries and deaths by about 50%. Similarly, motorcycle helmets are 37% effective in preventing fatal injuries and reduce the risk of by 69%, helping to limit the severity of from collisions. helmets also decrease the risk of head and brain injuries, contributing to overall in cycling accidents. These interventions directly address mechanisms of crashes that often result in internal hemorrhage from abdominal or thoracic impacts. Efforts to reduce violence-related penetrating injuries, which can cause severe internal bleeding, emphasize programs and regulatory measures. violence intervention initiatives, such as those improving physical environments through lot maintenance and economic support, have demonstrated success in lowering firearm-related incidents by addressing root causes like and access to weapons. Firearm regulations, including background checks and safe storage laws, have been associated with reductions in injuries in multiple studies, with child access prevention laws decreasing unintentional shootings by up to 78%. These approaches target high-incidence areas to interrupt cycles of and prevent . In sports and occupational settings, protective gear and protocols are essential for averting falls, impacts, and collisions that may lead to internal injuries. Helmets, pads, and mouthguards in contact like football reduce the incidence of severe impacts, while proper technique minimizes risk during activities prone to blunt force. Occupationally, the use of harnesses, hard hats, and systems prevents injuries from heights and struck-by s, with OSHA standards requiring such equipment to significantly lower fatality rates in and similar fields. programs emphasize hazard recognition and safe practices to further enhance protection. Public health campaigns play a crucial role in promoting awareness and behavioral change to curb trauma from impaired , a leading cause of injuries. efforts, such as those highlighting the dangers of , have strong evidence of effectiveness, reducing alcohol-related crashes resulting in injuries by a of 10%. These initiatives often target high-risk groups, including young adults and frequent nighttime drivers, through education on sobriety checkpoints and programs, thereby decreasing the likelihood of high-speed collisions that cause internal bleeding.

Medical prevention

Medical prevention of internal bleeding focuses on strategies to mitigate risks arising from chronic conditions and therapeutic interventions that predispose individuals to non-traumatic hemorrhage, such as gastrointestinal , peptic ulcers, and vascular aneurysms. Screening plays a critical role in identifying high-risk patients before bleeding occurs. For individuals with , guidelines recommend upper gastrointestinal upon diagnosis to screen for , with surveillance intervals tailored to findings: annual for small varices and every three years if no varices are present. Similarly, surveillance is advised for abdominal aortic aneurysms, with the U.S. Preventive Services recommending one-time screening via ultrasonography for men aged 65 to 75 years who have ever smoked, followed by periodic monitoring for those with aneurysms measuring 3.0 to 5.4 cm in diameter to detect expansion and prevent rupture. Medication management is essential to balance thrombotic and bleeding risks in patients on anticoagulants or prone to mucosal injury. Bridging therapy, involving short-acting heparin to temporarily replace warfarin or direct oral anticoagulants during procedures, is indicated for patients at high thromboembolic risk, such as those with recent venous thromboembolism, though recent guidelines emphasize avoiding bridging in most cases to minimize bleeding complications. For ulcer-prone individuals, particularly those on nonsteroidal anti-inflammatory drugs or dual antiplatelet therapy, (PPI) prophylaxis significantly reduces the incidence of peptic ulcer bleeding by suppressing and promoting mucosal healing. For patients with hereditary bleeding disorders such as hemophilia, prophylactic replacement therapy with clotting factors is recommended to prevent spontaneous internal bleeding, particularly in joints (hemarthrosis) and other sites. Guidelines suggest initiating prophylaxis early, ideally before age 3 years or after the first joint bleed, to maintain factor levels above 1% and reduce annual bleeding rates by up to 90%. Lifestyle modifications address underlying vascular pathologies that contribute to internal bleeding. substantially lowers the risk of , including aneurysmal rupture and hemorrhagic events, with benefits emerging within five years; for instance, quitting reduces the of cardiovascular events to levels approaching those of never-smokers after about five years. Dietary interventions for control, such as the (Dietary Approaches to Stop Hypertension) plan emphasizing fruits, vegetables, low-fat dairy, and reduced sodium intake, help maintain blood pressure below thresholds that predispose to , thereby preventing vascular rupture. Preventive measures against infectious causes include eradication of in at-risk populations to avert peptic formation and subsequent bleeding. Eradication therapy, typically involving a combined with antibiotics, reduces the risk of recurrent bleeding by up to 65% in the initial years post-treatment, particularly in patients with a history of aspirin-associated ulcers.

References

  1. https://my.clevelandclinic.org/health/diseases/internal-bleeding
  2. https://medlineplus.gov/ency/article/000045.htm
  3. https://www.medicalnewstoday.com/articles/320322
  4. https://www.ncbi.nlm.nih.gov/books/NBK470382/
  5. https://www.webmd.com/first-aid/internal-bleeding-causes-signs
  6. https://www.medicinenet.com/internal_bleeding/article.htm
  7. https://www.merckmanuals.com/home/injuries-and-poisoning/first-aid/internal-bleeding
  8. https://pmc.ncbi.nlm.nih.gov/articles/PMC10207757/
  9. https://journals.lww.com/jtrauma/fulltext/2006/06001/impact_of_hemorrhage_on_trauma_outcome__an.2.aspx
  10. https://pubmed.ncbi.nlm.nih.gov/39629687/
  11. https://pmc.ncbi.nlm.nih.gov/articles/PMC10694464/
  12. https://www.ahajournals.org/doi/10.1161/STROKEAHA.120.032550
  13. https://www.ahajournals.org/doi/10.1161/JAHA.122.026723
  14. https://www.sciencedirect.com/science/article/abs/pii/S0049384823000841
  15. https://my.clevelandclinic.org/health/articles/traumatic-injury
  16. https://www.ncbi.nlm.nih.gov/books/NBK470338/
  17. https://www.ncbi.nlm.nih.gov/books/NBK431087/
  18. https://rads.web.unc.edu/wp-content/uploads/sites/12234/2023/07/Vascular-Injury-Blunt-Abdominal-Trauma.pdf
  19. https://www.ncbi.nlm.nih.gov/books/NBK459123/
  20. https://www.ncbi.nlm.nih.gov/books/NBK564335/
  21. https://pmc.ncbi.nlm.nih.gov/articles/PMC2579530/
  22. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694464/
  23. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11497492/
  24. https://pmc.ncbi.nlm.nih.gov/articles/PMC11497492/
  25. https://pmc.ncbi.nlm.nih.gov/articles/PMC4231512/
  26. https://pmc.ncbi.nlm.nih.gov/articles/PMC4000612/
  27. https://pmc.ncbi.nlm.nih.gov/articles/PMC6379746/
  28. https://pmc.ncbi.nlm.nih.gov/articles/PMC6014846/
  29. https://www.ncbi.nlm.nih.gov/books/NBK441963/
  30. https://www.mayoclinic.org/diseases-conditions/abdominal-aortic-aneurysm/symptoms-causes/syc-20350688
  31. https://www.ncbi.nlm.nih.gov/books/NBK459176/
  32. https://www.ncbi.nlm.nih.gov/books/NBK551607/
  33. https://www.nhlbi.nih.gov/health/disseminated-intravascular-coagulation
  34. https://pmc.ncbi.nlm.nih.gov/articles/PMC9658286/
  35. https://pmc.ncbi.nlm.nih.gov/articles/PMC7724548/
  36. https://pmc.ncbi.nlm.nih.gov/articles/PMC2687658/
  37. https://pmc.ncbi.nlm.nih.gov/articles/PMC2780116/
  38. https://www.researchgate.net/publication/235727991_Management_of_Postoperative_Complications_Following_Splenectomy
  39. https://www.sciencedirect.com/science/article/pii/S0741521403017427
  40. https://pmc.ncbi.nlm.nih.gov/articles/PMC11231707/
  41. https://ashpublications.org/hematology/article/2020/1/642/474351/Combining-antiplatelet-and-anticoagulant-therapy
  42. https://www.ahajournals.org/doi/10.1161/circinterventions.117.005866
  43. https://www.ncbi.nlm.nih.gov/books/NBK558928/
  44. https://www.sciencedirect.com/science/article/abs/pii/S1096288314000163
  45. https://pmc.ncbi.nlm.nih.gov/articles/PMC10212795/
  46. https://pmc.ncbi.nlm.nih.gov/articles/PMC8590476/
  47. https://www.ncbi.nlm.nih.gov/books/NBK545263/
  48. https://www.ncbi.nlm.nih.gov/books/NBK482253/
  49. https://pmc.ncbi.nlm.nih.gov/articles/PMC6692728/
  50. https://www.ncbi.nlm.nih.gov/books/NBK513297/
  51. https://www.merckmanuals.com/professional/critical-care-medicine/shock-and-fluid-resuscitation/shock
  52. https://medlineplus.gov/ency/article/000167.htm
  53. https://www.ncbi.nlm.nih.gov/books/NBK431090/
  54. https://www.ncbi.nlm.nih.gov/books/NBK482194/
  55. https://www.mayoclinic.org/diseases-conditions/gastrointestinal-bleeding/symptoms-causes/syc-20372729
  56. https://www.ncbi.nlm.nih.gov/books/NBK560738/
  57. https://www.verywellhealth.com/internal-bleeding-signs-symptoms-complications-4172951
  58. https://www.aafp.org/pubs/afp/issues/2017/0301/p303.html
  59. https://www.ncbi.nlm.nih.gov/books/NBK6868/
  60. https://www.atsjournals.org/doi/10.1513/AnnalsATS.201308-280OC
  61. https://pmc.ncbi.nlm.nih.gov/articles/PMC7056343/
  62. https://www.ncbi.nlm.nih.gov/books/NBK459220/
  63. https://www.doh.wa.gov/Portals/1/Documents/Pubs/530168.pdf
  64. https://www.ncbi.nlm.nih.gov/books/NBK470479/
  65. https://pmc.ncbi.nlm.nih.gov/articles/PMC4056078/
  66. https://pmc.ncbi.nlm.nih.gov/articles/PMC6603326/
  67. https://www.ncbi.nlm.nih.gov/books/NBK470202/
  68. https://pmc.ncbi.nlm.nih.gov/articles/PMC3672480/
  69. https://www.ncbi.nlm.nih.gov/books/NBK499824/
  70. https://pmc.ncbi.nlm.nih.gov/articles/PMC4828865/
  71. https://www.nejm.org/doi/full/10.1056/NEJMvcm2107283
  72. https://www.acep.org/sonoguide/basic/fast
  73. https://jbsr.be/articles/10.5334/jbsr.3365
  74. https://ajronline.org/doi/10.2214/ajr.178.1.1780017
  75. https://www.sciencedirect.com/science/article/pii/S2211568415001904
  76. https://www.sciencedirect.com/science/article/pii/S2950162825000578
  77. https://www.rsna.org/news/2023/november/rsna-ai-challenge-abdominal-trauma-detection-results
  78. https://www.ahajournals.org/doi/10.1161/01.str.0000019882.06696.d6
  79. https://pmc.ncbi.nlm.nih.gov/articles/PMC5594987/
  80. https://www.facs.org/media/oxdjw5zj/imaging_guidelines.pdf
  81. https://www.east.org/education-resources/practice-management-guidelines/details/endotracheal-intubation-following-trauma
  82. https://www.ncbi.nlm.nih.gov/books/NBK558915/
  83. https://jts.health.mil/assets/docs/cpgs/Damage_Control_Resuscitation_12_Jul_2019_ID18.pdf
  84. https://jamanetwork.com/journals/jama/fullarticle/2107789
  85. https://pmc.ncbi.nlm.nih.gov/articles/PMC3177360/
  86. https://journals.lww.com/ajg/fulltext/2021/05000/acg_clinical_guideline__upper_gastrointestinal_and.14.aspx
  87. https://www.esge.com/endoscopic-diagnosis-and-management-of-nonvariceal-upper-gastrointestinal-hemorrhage-esge-update-2021
  88. https://journals.lww.com/joct/fulltext/2016/01010/damage_control_thoracic_surgery.4.aspx
  89. https://pmc.ncbi.nlm.nih.gov/articles/PMC8049761/
  90. https://pmc.ncbi.nlm.nih.gov/articles/PMC5051616/
  91. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)60835-5/fulltext
  92. http://journals.lww.com/jtrauma/Fulltext/2012/11004/Selective_nonoperative_management_of_blunt_splenic.4.aspx
  93. https://ccforum.biomedcentral.com/articles/10.1186/s13054-023-04327-7
  94. https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.16142
  95. https://pmc.ncbi.nlm.nih.gov/articles/PMC6516823/
  96. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2821815
  97. https://www.uptodate.com/contents/management-of-bleeding-in-patients-receiving-direct-oral-anticoagulants
  98. https://www.uspharmacist.com/article/understanding-uremia-42384
  99. https://pubmed.ncbi.nlm.nih.gov/25933676/
  100. https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13930
  101. https://www.mdpi.com/1422-0067/24/4/4103
  102. https://www.ncbi.nlm.nih.gov/books/NBK564427/
  103. https://www.atsjournals.org/doi/10.1164/rccm.201907-1283CI
  104. https://www.mayoclinic.org/diseases-conditions/ards/diagnosis-treatment/drc-20355581
  105. https://pmc.ncbi.nlm.nih.gov/articles/PMC7296358/
  106. https://www.wjgnet.com/2220-3141/full/v14/i3/102834.htm
  107. https://pmc.ncbi.nlm.nih.gov/articles/PMC6426535/
  108. https://www.ahajournals.org/doi/10.1161/STR.0000000000000407
  109. https://pmc.ncbi.nlm.nih.gov/articles/PMC11649738/
  110. https://pmc.ncbi.nlm.nih.gov/articles/PMC12523585/
  111. https://pmc.ncbi.nlm.nih.gov/articles/PMC3254043/
  112. https://pubmed.ncbi.nlm.nih.gov/12813333/
  113. https://pmc.ncbi.nlm.nih.gov/articles/PMC4129771/
  114. https://www.ncbi.nlm.nih.gov/books/NBK538191/
  115. https://www.ncbi.nlm.nih.gov/books/NBK537224/
  116. https://pmc.ncbi.nlm.nih.gov/articles/PMC4626906/
  117. https://pmc.ncbi.nlm.nih.gov/articles/PMC9340208/
  118. https://pmc.ncbi.nlm.nih.gov/articles/PMC3051203/
  119. https://www.ncbi.nlm.nih.gov/books/NBK448124/
  120. https://pmc.ncbi.nlm.nih.gov/articles/PMC12183391/
  121. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2024.1399429/full
  122. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2789511
  123. https://pmc.ncbi.nlm.nih.gov/articles/PMC9894600/
  124. https://www.nature.com/articles/s41598-020-77556-3
  125. https://pubmed.ncbi.nlm.nih.gov/33538617/
  126. https://www.mayoclinic.org/tests-procedures/splenectomy/about/pac-20395066
  127. https://www.bmj.com/content/345/bmj.e5166
  128. https://pmc.ncbi.nlm.nih.gov/articles/PMC7468220/
  129. https://archive.cdc.gov/www_cdc_gov/policy/hi5/motorcycleinjury/index.html
  130. https://www.cdc.gov/pedestrian-bike-safety/about/bicycle-safety.html
  131. https://www.cdc.gov/firearm-violence/prevention/index.html
  132. https://www.aafp.org/about/policies/all/gun-violence.html
  133. https://www.cdc.gov/heads-up/prevention/index.html
  134. https://www.osha.gov/fall-protection
  135. https://stacks.cdc.gov/view/cdc/164233
  136. https://www.cdc.gov/impaired-driving/strategies/index.html
  137. https://www.uptodate.com/contents/primary-prevention-of-bleeding-from-esophageal-varices-in-patients-with-cirrhosis
  138. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/abdominal-aortic-aneurysm-screening
  139. https://www.aium.org/docs/default-source/resources/guidelines/abdominalaorta.pdf?sfvrsn=7a8e4b87_1
  140. https://www.jacc.org/doi/10.1016/j.jacc.2016.11.024
  141. https://pmc.ncbi.nlm.nih.gov/articles/PMC6004044/
  142. https://www.cdc.gov/hemophilia/treatment/index.html
  143. https://pmc.ncbi.nlm.nih.gov/articles/PMC7399440/
  144. https://pmc.ncbi.nlm.nih.gov/articles/PMC4366416/
  145. https://www.thelancet.com/article/S0140-6736(22)01843-8/fulltext
Add your contribution
Related Hubs
User Avatar
No comments yet.